Built for the next generation of biotech leaders.
When you join the BioCentury community, our team of Ph.D.s, analysts and industry experts becomes an extension of your team, helping you answer critical questions, decipher strategic trends, objectively evaluate product and business strategies, and assess competitive, financial and policy risks. We also help you to build your network by connecting you to the who’s who of the industry.
Headquartered in Redwood City, Calif., BioCentury has offices throughout the U.S. and in the U.K.
No matter where you are in the drug development process — from idea to patient — BioCentury’s intelligence platform helps you answer critical questions that are vital to the transformation, growth and overall success of your company. Subscribers use our essential analysis and insights to create business strategies, discover investment opportunities, find partners, analyze deals and competitive landscapes, navigate emerging markets, assess regulatory changes, create profitable pricing models, and develop networks.
BioCentury's BCIQ is unlike any other business intelligence and research tool on the market. It combines over 25 years of BioCentury's leading analysis of the biopharma industry with fully vetted and meticulously maintained data. BCIQ is designed and curated by BioCentury’s industry experts and data team to support the biopharma industry’s financing, investing and dealmaking activities.
For more than 20 years, BioCentury events have been where CEOs, investors, and biopharma decision makers gather to network, partner, and debate critical issues facing the industry. BioCentury events are designed for C-level executives to build their networks and get work done.
Bio€quity Europe, launched in 2000, is the industry’s premier CEO and investor conference. The BioCentury-BayHelix China Healthcare Summit, launched in 2014 in Shanghai, is the place to pressure test your cross-border strategy and build C-level relationships. The BioCentury-BayHelix East-West Summit, launched in the U.S. in 2022, is where industry leaders and investors gather to debate global development strategy, and to network with peers from both the East and West.
BioCentury's Editorial and Research Team has been informing C-level biopharma executives, investors and researchers since 1993. Comprising industry-recognized business and science editors, writers and analysts, the team delivers trusted intelligence 24/7.
Our Management Team includes executives with backgrounds in the biopharma industry, finance, publishing, events and international business.